Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2021 Filed Apr 6, 2021 16:30 UTC |
COHEN MARC ADirector · 10% owner
|
GrantCommon Stock | 553 | $37.51 | $20,743.03 |
DisclosureSEC source: 0001209191-21-025661 · doc4.xml · nonDerivative · entry 1 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,119 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 16:30 UTC |
Salter MalcolmDirector
|
GrantCommon Stock | 359 | $37.51 | $13,466.09 |
DisclosureSEC source: 0001209191-21-025663 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,353 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:31 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 233 | $37.51 | $8,739.83 |
DisclosureSEC source: 0001209191-21-025665 · doc4.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,157 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:30 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionCommon Stock · Derivative | 15,000 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001209191-21-025664 · doc4.xml · derivative · entry 4 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,292 Underlying: Common Stock · 15,000 shares Expires 2029-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. F4 · derivative.exercise_date: 25% of this option vested and became exercisable on February 14, 2020, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:30 UTC |
Crystal AdamChief Medical Officer
|
SaleCommon Stock | 10,879 | $38.00 | $413,407.44 |
DisclosureSEC source: 0001209191-21-025664 · doc4.xml · nonDerivative · entry 3 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.59 to $38.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:30 UTC |
Crystal AdamChief Medical Officer
|
SaleCommon Stock | 4,121 | $37.16 | $153,128.53 |
DisclosureSEC source: 0001209191-21-025664 · doc4.xml · nonDerivative · entry 2 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,879 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.545 to $37.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:30 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionCommon Stock | 15,000 | $6.50 | $97,500.00 |
DisclosureSEC source: 0001209191-21-025664 · doc4.xml · nonDerivative · entry 1 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:17 UTC |
Dubin GlennDirector
|
GrantStock Option (Right to Buy) · Derivative | 41,200 | $0.00 Strike: $44.64 | $0.00 |
DisclosureSEC source: 0001209191-21-020777 · doc4.xml · derivative · entry 1 Dubin Glenn · CIK 0001308597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,200 Underlying: Common Stock · 41,200 shares Expires 2031-03-11 F1 · derivative.exercise_date: One-third of this option shall vest and become exercisable on March 12, 2022, with the remainder vesting in eight equal quarterly installments thereafter. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 16:15 UTC |
COHEN MARC ADirector · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 536 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001209191-21-012339 · doc4.xml · derivative · entry 4 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,209 Underlying: Common Stock · 536 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such date. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 16:15 UTC |
COHEN MARC ADirector · 10% owner
|
Exercise / conversionCommon Stock | 536 | $2.11 | $1,130.96 |
DisclosureSEC source: 0001209191-21-012339 · doc4.xml · nonDerivative · entry 1 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:16 UTC |
Wahlberg Laura JeanVP of Finance Corp Controller
|
GrantStock Option (Right to Buy) · Derivative | 23,100 | $0.00 Strike: $45.54 | $0.00 |
DisclosureSEC source: 0001209191-21-010711 · doc4.xml · derivative · entry 1 Wahlberg Laura Jean · CIK 0001825153 · VP of Finance Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,100 Underlying: Common Stock · 23,100 shares Expires 2031-02-10 F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:15 UTC |
Fisher StewartChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 94,950 | $0.00 Strike: $45.54 | $0.00 |
DisclosureSEC source: 0001209191-21-010710 · doc4.xml · derivative · entry 1 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,950 Underlying: Common Stock · 94,950 shares Expires 2031-02-10 F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:15 UTC |
Crystal AdamChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 87,850 | $0.00 Strike: $45.54 | $0.00 |
DisclosureSEC source: 0001209191-21-010707 · doc4.xml · derivative · entry 1 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,850 Underlying: Common Stock · 87,850 shares Expires 2031-02-10 F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:15 UTC |
Siegel JolieChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 84,850 | $0.00 Strike: $45.54 | $0.00 |
DisclosureSEC source: 0001209191-21-010708 · doc4.xml · derivative · entry 1 Siegel Jolie · CIK 0001768223 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,850 Underlying: Common Stock · 84,850 shares Expires 2031-02-10 F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,929 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 8 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,514 Underlying: Common Stock · 5,929 shares Expires 2028-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72). F3 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on April 24, 2018. The terms of the original grant provide that 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,371 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 7 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,371 Underlying: Common Stock · 2,371 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on May 2, 2017, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,929 | $3.71 | $21,996.59 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 4 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72). Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,371 | $2.11 | $5,002.81 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 3 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 889 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001209191-21-005374 · doc4.xml · derivative · entry 11 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,446 Underlying: Common Stock · 889 shares Expires 2030-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal quarterly installments, with the first installment vesting on October 1, 2020. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 121 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001209191-21-005374 · doc4.xml · derivative · entry 10 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 121 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: The Form 3 filed on October 1, 2020 included an incorrect number of underlying securities in Table II, Column 3 (118). F7 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on January 1, 2017, with the remainder vesting in 16 equal quarterly installments thereafter. F6 · derivative.underlying_shares: The Form 3 filed on October 1, 2020 included an incorrect number of underlying securities in Table II, Column 3 (118). Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 538 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001209191-21-005374 · doc4.xml · derivative · entry 9 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,207 Underlying: Common Stock · 538 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionCommon Stock | 889 | $4.98 | $4,427.22 |
DisclosureSEC source: 0001209191-21-005374 · doc4.xml · nonDerivative · entry 3 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionCommon Stock | 121 | $2.11 | $255.31 |
DisclosureSEC source: 0001209191-21-005374 · doc4.xml · nonDerivative · entry 2 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 21:34 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionCommon Stock | 538 | $2.11 | $1,135.18 |
DisclosureSEC source: 0001209191-21-005374 · doc4.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,701 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 6 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,443 Underlying: Common Stock · 9,701 shares Expires 2028-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72). F3 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on April 24, 2018. The terms of the original grant provide that 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| December 11, 2020 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,743 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 5 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,742 Underlying: Common Stock · 4,743 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on May 2, 2017, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| December 11, 2020 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionCommon Stock | 9,701 | $3.71 | $35,990.71 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 2 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72). Read SEC document |
| December 11, 2020 Filed Feb 4, 2021 21:35 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionCommon Stock | 4,743 | $2.11 | $10,007.73 |
DisclosureSEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 1 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:24 UTC |
COHEN ALAIN JDirector · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 20,952,403 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027690 · doc4.xml · derivative · entry 6 COHEN ALAIN J · CIK 0001132946 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P. Disclosed balance after: 0 Underlying: Common Stock · 2,484,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:24 UTC |
COHEN ALAIN JDirector · 10% owner
|
ConversionSeries A Preferred Stock · Derivative | 12,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027690 · doc4.xml · derivative · entry 5 COHEN ALAIN J · CIK 0001132946 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,482,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:24 UTC |
COHEN ALAIN JDirector · 10% owner
|
ConversionSeries Seed Preferred Stock · Derivative | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027690 · doc4.xml · derivative · entry 4 COHEN ALAIN J · CIK 0001132946 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 237,149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:24 UTC |
COHEN ALAIN JDirector · 10% owner
|
ConversionCommon Stock | 2,484,425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027690 · doc4.xml · nonDerivative · entry 3 COHEN ALAIN J · CIK 0001132946 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P. Disclosed balance after: 2,484,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:24 UTC |
COHEN ALAIN JDirector · 10% owner
|
ConversionCommon Stock | 1,482,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027690 · doc4.xml · nonDerivative · entry 2 COHEN ALAIN J · CIK 0001132946 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,719,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:24 UTC |
COHEN ALAIN JDirector · 10% owner
|
ConversionCommon Stock | 237,149 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027690 · doc4.xml · nonDerivative · entry 1 COHEN ALAIN J · CIK 0001132946 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 237,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:28 UTC |
COHEN MARC ADirector · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 20,952,403 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027697 · doc4.xml · derivative · entry 7 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P. Disclosed balance after: 0 Underlying: Common Stock · 2,484,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:28 UTC |
COHEN MARC ADirector · 10% owner
|
ConversionSeries A Preferred Stock · Derivative | 12,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027697 · doc4.xml · derivative · entry 6 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,482,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:28 UTC |
COHEN MARC ADirector · 10% owner
|
ConversionSeries Seed Preferred Stock · Derivative | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027697 · doc4.xml · derivative · entry 5 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 237,149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:28 UTC |
COHEN MARC ADirector · 10% owner
|
PurchaseCommon Stock | 5,030 | $19.00 | $95,570.00 |
DisclosureSEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 4 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,030 Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:28 UTC |
COHEN MARC ADirector · 10% owner
|
ConversionCommon Stock | 2,484,425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 3 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P. Disclosed balance after: 2,484,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:28 UTC |
COHEN MARC ADirector · 10% owner
|
ConversionCommon Stock | 1,482,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 2 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,852,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:28 UTC |
COHEN MARC ADirector · 10% owner
|
ConversionCommon Stock | 237,149 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 1 COHEN MARC A · CIK 0001132945 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 370,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:26 UTC |
Salter MalcolmDirector
|
ConversionSeries B Preferred Stock · Derivative | 23,809 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027692 · doc4.xml · derivative · entry 5 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,823 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:26 UTC |
Salter MalcolmDirector
|
ConversionSeries A Preferred Stock · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027692 · doc4.xml · derivative · entry 4 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:26 UTC |
Salter MalcolmDirector
|
PurchaseCommon Stock | 1,315 | $19.00 | $24,985.00 |
DisclosureSEC source: 0000899243-20-027692 · doc4.xml · nonDerivative · entry 3 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,994 Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:26 UTC |
Salter MalcolmDirector
|
ConversionCommon Stock | 2,823 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027692 · doc4.xml · nonDerivative · entry 2 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:26 UTC |
Salter MalcolmDirector
|
ConversionCommon Stock | 11,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027692 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:27 UTC |
DOWNEY BRUCEDirector
|
ConversionSeries B Preferred Stock · Derivative | 2,128,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027695 · doc4.xml · derivative · entry 4 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 252,394 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:27 UTC |
DOWNEY BRUCEDirector
|
ConversionSeries A Preferred Stock · Derivative | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027695 · doc4.xml · derivative · entry 3 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 237,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:27 UTC |
DOWNEY BRUCEDirector
|
ConversionCommon Stock | 252,394 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027695 · doc4.xml · nonDerivative · entry 2 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 21:27 UTC |
DOWNEY BRUCEDirector
|
ConversionCommon Stock | 237,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-027695 · doc4.xml · nonDerivative · entry 1 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.